Replies to Post #4924 onRevance Therapeutics Inc (RVNC)

Replies to post #4924 on Revance Therapeutics Inc (RVNC)

Replies to #4924 on Revance Therapeutics Inc (RVNC)

10/31/23 6:52 PM

#4926 RE: soma2022 #4924

Cost is the problem and also the fact that management already cashed in on options.

10/31/23 6:57 PM

#4927 RE: soma2022 #4924

My Q3 2023 Income Statement Estimates:
…Service/HintMD: $3.5M

The Opul/HintMD business has been discontinued.